Investor & Partner Preview · April 2026
Decoding Skin
Glacies Biome helps longevity, wellness, aesthetic, and skincare clinics hyper-personalize care, increase loyalty, and turn every patient journey into measurable outcome data.
Strong commercial traction
Paying customers in the EU and Switzerland with +$1.38M ARR contracts signed; US expansion underway.
B2B platform for personalized skin health
Multi-modal AI links long-read 16S skin microbiome data, facial visual analysis, lifestyle, treatment history, and environment to generate personalized routines, clinic protocols, and longitudinal skin intelligence.
Supported by
What we're building
A molecular-level platform for
aesthetic clinics
built on microbiome science, AI and a proprietary collagen biomarker technology
We save clinicians hours and generate treatment plans and longitudinal outcome data for driving customer royalty.
Long-read 16S microbiome data helps Glacies understand how skin is likely to respond across treatments, products, and recovery windows.
Patients start with a positive, goal-led intake and guided face scan. Glacies turns photos, baseline context, and skin data into a clear first plan without making the experience feel clinical or overwhelming.